Alexey L. Margolin
Fondateur chez ALLENA PHARMACEUTICALS, INC.
Postes actifs de Alexey L. Margolin
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALLENA PHARMACEUTICALS, INC. | Président | 01/02/2019 | - |
Fondateur | 24/06/2011 | - | |
Directeur/Membre du Conseil | 01/09/2011 | 01/02/2019 | |
Directeur Général | 01/09/2011 | 01/02/2019 | |
President | 24/06/2011 | 01/02/2017 | |
Secrétaire Général | 24/06/2011 | 01/02/2019 | |
Treasurer | 24/06/2011 | 01/02/2019 | |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Directeur/Membre du Conseil | - | - |
Fondateur | 01/09/2011 | - | |
Directeur Général | 01/09/2011 | 01/04/2014 | |
Président | 01/04/2014 | - | |
President | 01/09/2011 | 24/07/2013 | |
Anagram Therapeutics, Inc.
Anagram Therapeutics, Inc. Medical/Nursing ServicesHealth Services Anagram Therapeutics, Inc. provides healthcare services. The company is based in Framingham, MA. The CEO of the company is Robert Gallotto. | Président | - | - |
Historique de carrière de Alexey L. Margolin
Anciens postes connus de Alexey L. Margolin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Directeur Général | 01/07/2008 | 01/12/2010 |
Fondateur | 01/07/2008 | 01/12/2010 | |
President | 01/07/2008 | 01/12/2010 | |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Directeur Technique/Scientifique/R&D | 01/01/1993 | 31/12/2007 |
Formation de Alexey L. Margolin
Moscow University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Russie | 2 |
Opérationnelle
Chief Executive Officer | 3 |
Chairman | 3 |
Founder | 3 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ALLENA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Health Technology |
Anagram Therapeutics, Inc.
Anagram Therapeutics, Inc. Medical/Nursing ServicesHealth Services Anagram Therapeutics, Inc. provides healthcare services. The company is based in Framingham, MA. The CEO of the company is Robert Gallotto. | Health Services |
- Bourse
- Insiders
- Alexey L. Margolin
- Expérience